Cite
Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.
MLA
Ferguson, Gary T., et al. “Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.” Chronic Obstructive Pulmonary Diseases (Miami, Fla.), vol. 6, no. 2, Apr. 2019, pp. 154–65. EBSCOhost, https://doi.org/10.15326/jcopdf.6.2.2018.0152.
APA
Ferguson, G. T., Feldman, G., Pudi, K. K., Barnes, C. N., Moran, E. J., Haumann, B., Pendyala, S., & Crater, G. (2019). Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials. Chronic Obstructive Pulmonary Diseases (Miami, Fla.), 6(2), 154–165. https://doi.org/10.15326/jcopdf.6.2.2018.0152
Chicago
Ferguson, Gary T, Gregory Feldman, Krishna K Pudi, Chris N Barnes, Edmund J Moran, Brett Haumann, Srikanth Pendyala, and Glenn Crater. 2019. “Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.” Chronic Obstructive Pulmonary Diseases (Miami, Fla.) 6 (2): 154–65. doi:10.15326/jcopdf.6.2.2018.0152.